SP1 and non-small cell lung carcinoma: Moreover, our in vivo data was consistent with in vitro data, further validating the anticancer and anti-angiogenesis of Curcumol on NSCLC xenograft tumors via regulation of SP1, miR-125b-5p and VEGFA expression.